← Back to Eris Lifesciences Ltd Overview

📊Financials 📈PE Ratio 🥧Shareholding 💰Dividend 📋Quarterly ⚖️Balance Sheet 💹P&L 🌊Cash Flow

ERISPharmaceuticals

Eris Lifesciences Ltd — Financial Ratios & Key Metrics

₹1297.20

+2.05%

P/E Ratio51.82xIndustry: 31.77x

ROE12.88%Return on equity

ROCE12.22%Return on capital

Debt/Equity0.77Low debt

💎

Valuation & Profitability

P/E Ratio

51.82x

Industry Average P/E

31.77x

Dividend Yield

0.46%

Market Cap

₹21.54K (Cr)

Sales Growth 5Y

21.92%

Profit Growth 5Y

3.71%

EPS Growth 5Y

3.65%

OPM 5Y Avg

34.48%

📉

Price Returns

1 Month

-0.64%

3 Months

-10.70%

6 Months

-1.46%

1 Year

+9.81%

52W Low

₹1097

Current

₹1297

52W High

₹1910

25% of 52-week range — Near lows

🔬

Technical Indicators

Neutral

Momentum is balanced — neither overbought nor oversold.

SMA 50

₹1373

▼ Price below SMA 50 — Bearish

SMA 200

₹1586

▼ Long-term downtrend

Volume Signal

147% of avg

Above average volume — strong conviction behind price move

Technical indicators are for educational purposes only. Not investment advice.

More on Eris Lifesciences Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.